NRXP icon

NRX Pharmaceuticals
NRXP

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$35
1,121% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
50% 1-yr NRXP win rate
9 Mar ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Patrick Trucchio
40% 1-yr NRXP win rate
3 Mar ‘26 1 month ago
BTIG
BTIG
Thomas Shrader
33% 1-yr NRXP win rate
18 Feb ‘26 2 months ago